Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, Dirk M. van der Steen et al.|Journal of Clinical Investigation|2019Cited by 232
Mutated NPM1 As Target for Immunotherapy of Acute Myeloid LeukemiaDyantha I. van der Lee, Marieke Griffioen, Helena M. Bijen et al.|Blood|2017Cited by 2
Abstract A044: Mutated NPM1 as target for immunotherapy of acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, Rogier M. Reijmers et al.|Cancer Immunology Research|2019Cited by 0